Mission Pharmacal Header

Mission Pharmacal Header

X

Find Novel Neurology Drugs in Clinical Development in GERMANY

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Filters

Reset Filter

All Developments

Product Type

Companies

[{"company":"Evotec","sponsor":"Bristol Myers Squibb","pharmaFlowCategory":"D","amount":"$6.0 million","upfrontCash":"Undisclosed","newsHeadline":"Evotec and BMS Expand IPSC Collaboration","therapeuticArea":"Neurology","highestDevelopmentStatus":"Undisclosed","country":"GERMANY","productType":"Cell and Gene therapy","productStatus":"Approved","date":"January 2020","url1":"","url2":"","graph1":"Cell and Gene therapy","graph2":"Evotec"}]

Evotec

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Evotec and BMS Expand IPSC Collaboration

Details:

This partnership pursues an innovative approach to identifying and creating novel medicines using several of Evotec's technology technologies in tandem with the human iPSC-based platform.

Lead Product(s): Induced pluripotent stem cells

Therapeutic Area: Neurology Product Name: Undisclosed

Highest Development Status: Undisclosed Product Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Bristol Myers Squibb

Deal Size: $6.0 million Upfront Cash: Undisclosed

Deal Type: Collaboration January 07, 2020

ASK
US

Upload
your Pipeline Activity

POST ENQUIRY